Annual CFF
$0.00
-$7900.00-100.00%
December 31, 2023
Summary
- As of February 12, 2025, MNOV annual cash flow from financing activities is $0.00, with the most recent change of -$7900.00 (-100.00%) on December 31, 2023.
- During the last 3 years, MNOV annual CFF has fallen by -$7.11 million (-100.00%).
- MNOV annual CFF is now -100.00% below its all-time high of $110.91 million, reached on December 31, 2005.
Performance
MNOV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 30, 2024
Summary
- MNOV quarterly cash flow from financing activities is not available.
Performance
MNOV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 30, 2024
Summary
- MNOV TTM cash flow from financing activities is not available.
Performance
MNOV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MNOV Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
MNOV Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||||
| 5 y | 5-year | -100.0% | at low | ||||
| alltime | all time | -100.0% | +100.0% |
MediciNova Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | $7900.00(-100.0%) | $0.00(0.0%) | $7900.00(-83.0%) |
| Sep 2022 | - | $0.00(-100.0%) | $46.60 K(-84.3%) |
| Jun 2022 | - | $7900.00(-79.6%) | $296.20 K(-98.6%) |
| Dec 2021 | $20.78 M(+192.4%) | $38.70 K(-84.5%) | $20.78 M(-1.5%) |
| Sep 2021 | - | $249.60 K(-36.0%) | $21.10 M(-18.8%) |
| Jun 2021 | - | $389.70 K(-98.1%) | $25.98 M(-3.0%) |
| Mar 2021 | - | $20.10 M(+5503.5%) | $26.79 M(+277.0%) |
| Dec 2020 | $7.11 M(-33.1%) | $358.70 K(-93.0%) | $7.11 M(-29.5%) |
| Sep 2020 | - | $5.13 M(+327.0%) | $10.08 M(+24.0%) |
| Jun 2020 | - | $1.20 M(+186.6%) | $8.13 M(+14.4%) |
| Mar 2020 | - | $418.90 K(-87.4%) | $7.11 M(-33.1%) |
| Dec 2019 | $10.62 M(-75.2%) | $3.33 M(+4.9%) | $10.62 M(+20.6%) |
| Sep 2019 | - | $3.17 M(+1659.9%) | $8.80 M(+56.0%) |
| Jun 2019 | - | $180.40 K(-95.4%) | $5.64 M(-26.8%) |
| Mar 2019 | - | $3.93 M(+159.3%) | $7.70 M(-82.0%) |
| Dec 2018 | $42.81 M(+296.5%) | $1.52 M(+9867.8%) | $42.81 M(-6.5%) |
| Sep 2018 | - | $15.20 K(-99.3%) | $45.80 M(-7.2%) |
| Jun 2018 | - | $2.24 M(-94.3%) | $49.35 M(-0.8%) |
| Mar 2018 | - | $39.03 M(+766.9%) | $49.77 M(+360.9%) |
| Dec 2017 | $10.80 M(+24.6%) | $4.50 M(+26.3%) | $10.80 M(+65.4%) |
| Sep 2017 | - | $3.56 M(+33.8%) | $6.53 M(+119.2%) |
| Jun 2017 | - | $2.66 M(+3924.3%) | $2.98 M(+294.3%) |
| Mar 2017 | - | $66.20 K(-71.9%) | $755.50 K(-91.3%) |
| Dec 2016 | $8.67 M(-50.7%) | $235.20 K(+1604.3%) | $8.67 M(+3.0%) |
| Sep 2016 | - | $13.80 K(-96.9%) | $8.41 M(-65.8%) |
| Jun 2016 | - | $440.30 K(-94.5%) | $24.60 M(-1.2%) |
| Mar 2016 | - | $7.98 M(<-9900.0%) | $24.90 M(+41.8%) |
| Dec 2015 | $17.56 M(+322.0%) | -$17.90 K(-100.1%) | $17.56 M(-4.3%) |
| Sep 2015 | - | $16.20 M(+2086.3%) | $18.35 M(+741.0%) |
| Jun 2015 | - | $741.10 K(+16.1%) | $2.18 M(+47.3%) |
| Mar 2015 | - | $638.10 K(-17.1%) | $1.48 M(-64.4%) |
| Dec 2014 | $4.16 M(-68.9%) | $769.50 K(+2210.8%) | $4.16 M(+20.2%) |
| Sep 2014 | - | $33.30 K(-18.0%) | $3.46 M(-12.6%) |
| Jun 2014 | - | $40.60 K(-98.8%) | $3.96 M(-73.7%) |
| Mar 2014 | - | $3.32 M(+4574.4%) | $15.05 M(+12.6%) |
| Dec 2013 | $13.37 M | $71.00 K(-86.7%) | $13.37 M(-2.8%) |
| Sep 2013 | - | $534.30 K(-95.2%) | $13.75 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $11.13 M(+580.5%) | $14.14 M(+348.6%) |
| Mar 2013 | - | $1.64 M(+261.2%) | $3.15 M(+104.0%) |
| Dec 2012 | $1.55 M(+892.4%) | $452.80 K(-51.1%) | $1.55 M(-81.6%) |
| Sep 2012 | - | $926.80 K(+573.1%) | $8.40 M(+15.6%) |
| Jun 2012 | - | $137.70 K(+393.5%) | $7.27 M(-205.2%) |
| Mar 2012 | - | $27.90 K(-99.6%) | -$6.91 M(-4539.1%) |
| Dec 2011 | $155.70 K(-116.8%) | $7.31 M(-3642.3%) | $155.60 K(-102.2%) |
| Sep 2011 | - | -$206.30 K(-98.5%) | -$7.08 M(-19.5%) |
| Jun 2011 | - | -$14.04 M(-298.0%) | -$8.79 M(-215.5%) |
| Mar 2011 | - | $7.09 M(+9096.8%) | $7.61 M(-920.9%) |
| Dec 2010 | -$926.60 K(-105.1%) | $77.10 K(-104.0%) | -$926.70 K(-4.2%) |
| Sep 2010 | - | -$1.92 M(-181.4%) | -$967.70 K(-187.3%) |
| Jun 2010 | - | $2.36 M(-263.5%) | $1.11 M(-176.5%) |
| Mar 2010 | - | -$1.44 M(-4098.1%) | -$1.45 M(-108.0%) |
| Dec 2009 | $18.09 M(>+9900.0%) | $36.10 K(-76.9%) | $18.09 M(+0.2%) |
| Sep 2009 | - | $156.50 K(-178.8%) | $18.06 M(+0.6%) |
| Jun 2009 | - | -$198.50 K(-101.1%) | $17.94 M(-1.1%) |
| Mar 2009 | - | $18.10 M(>+9900.0%) | $18.14 M(>+9900.0%) |
| Dec 2008 | $86.70 K(-99.2%) | $0.00(-100.0%) | $86.80 K(0.0%) |
| Sep 2008 | - | $43.40 K(>+9900.0%) | $86.80 K(+12.4%) |
| Jun 2008 | - | $0.00(-100.0%) | $77.20 K(+3.8%) |
| Mar 2008 | - | $43.40 K(>+9900.0%) | $74.40 K(-99.3%) |
| Dec 2007 | $10.67 M(-1076.1%) | $0.00(-100.0%) | $10.67 M(+1.7%) |
| Sep 2007 | - | $33.80 K(-1307.1%) | $10.49 M(+0.9%) |
| Jun 2007 | - | -$2800.00(-100.0%) | $10.40 M(+1.5%) |
| Mar 2007 | - | $10.64 M(-6075.0%) | $10.24 M(-1036.8%) |
| Dec 2006 | -$1.09 M(-101.0%) | -$178.10 K(+199.3%) | -$1.09 M(+4.4%) |
| Sep 2006 | - | -$59.50 K(-63.0%) | -$1.05 M(-2.7%) |
| Jun 2006 | - | -$160.90 K(-76.8%) | -$1.08 M(-38.7%) |
| Mar 2006 | - | -$694.90 K(+424.5%) | -$1.76 M(-101.6%) |
| Dec 2005 | $110.91 M(+87.4%) | -$132.50 K(+49.7%) | $110.91 M(+0.9%) |
| Sep 2005 | - | -$88.50 K(-89.5%) | $109.96 M(-28.3%) |
| Jun 2005 | - | -$842.00 K(-100.8%) | $153.45 M(-7.4%) |
| Mar 2005 | - | $111.97 M(<-9900.0%) | $165.67 M(+179.9%) |
| Dec 2004 | $59.18 M(+494.4%) | -$1.08 M(-102.5%) | $59.18 M(-1.8%) |
| Sep 2004 | - | $43.40 M(+281.5%) | $60.26 M(+257.5%) |
| Jun 2004 | - | $11.38 M(+107.6%) | $16.86 M(+207.6%) |
| Mar 2004 | - | $5.48 M | $5.48 M |
| Dec 2003 | $9.96 M | - | - |
FAQ
- What is MediciNova annual cash flow from financing activities?
- What is the all time high annual CFF for MediciNova?
- What is MediciNova annual CFF year-on-year change?
- What is the all time high quarterly CFF for MediciNova?
- What is the all time high TTM CFF for MediciNova?
What is MediciNova annual cash flow from financing activities?
The current annual CFF of MNOV is $0.00
What is the all time high annual CFF for MediciNova?
MediciNova all-time high annual cash flow from financing activities is $110.91 M
What is MediciNova annual CFF year-on-year change?
Over the past year, MNOV annual cash flow from financing activities has changed by -$7900.00 (-100.00%)
What is the all time high quarterly CFF for MediciNova?
MediciNova all-time high quarterly cash flow from financing activities is $111.97 M
What is the all time high TTM CFF for MediciNova?
MediciNova all-time high TTM cash flow from financing activities is $165.67 M